BRIVEKIMIG
UNII XX2BGT8CLL

Substance Identification & Data

This profile provides standardized clinical and technical data for Brivekimig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XX2BGT8CLL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2834733-45-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XX2BGT8CLL

CAS Registry Number

2834733-45-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BRIVEKIMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C206890

National Cancer Institute reference terminology for clinical and research data.

INN ID

13019

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-159

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brivekimig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRIVEKIMIG

Common Names & Synonyms

BRIVEKIMIG [INN]

BRIVEKIMIG [USAN]

IMMUNOGLOBULIN IG SINGLE CHAIN OF 5 VH (VH-VH-VH'-VH''-VH') MONOMER, ANTI-(HOMO SAPIENS TNFSF4 (TNF SUPERFAMILY MEMBER 4, TUMOR NECROSIS FACTOR SUPERFAMILY MEMBER 4, OX40 LIGAND, OX40L, TAX TRANSCRIPTIONALLYACTIVATED GLYCOPROTEIN 1, TXGP1, GP34, CD252)), ANTI-(HOMO SAPIENS TNF(TUMOR NECROSIS FACTOR, TNF SUPERFAMILY MEMBER 2, TNFSF2, TNF-ALPHA, TNFA)) AND ANTI-(HOMO SAPIENS ALB (ALBUMIN, HUMAN SERUM ALBUMIN, HSA)), MONOCLONAL ANTIBODY VH-VH-VH'-VH''-VH', TRISPECIFIC, PENTAVALENT

IMMUNOGLOBULIN, BISPECIFIC, PENTAVALENT, ANTI-(HUMAN CD252 ANTIGEN) (HUMAN-CAMELIDEA MONOCLONAL 1E07 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (G(GGGS)2) FUSION PROTEIN WITH ANTI-(HUMAN CD252 ANTIGEN) (HUMAN-CAMELIDEA MONOCLONAL 1E07 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (G(GGGS)2) FUSION PROTEIN WITH ANTI-(HUMAN TUMOR NECROSIS FACTOR-.ALPHA.) (HUMAN-CAMELIDEA MONOCLONAL 1C02 SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (G(GGGS)2) FUSION PROTEIN WITH ANTI-(HUMAN SERUM ALBUMIN) (HUMAN-CAMELIDEA MONOCLONAL ALB SINGLE-DOMAIN VHH FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (G(GGGS)2) FUSION PROTEIN WITH ANTI-(HUMAN TUMOR NECROSIS FACTOR-.ALPHA.) (HUMAN-CAMELIDEA MONOCLONAL 1C02 SINGLE-DOMAIN VHH FRAGMENT)